
Aurora Cannabis Inc. (ACB), announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021 on Thursday, February 10th, 2022, as follows:
Q2 Financial Highlights
(Unless otherwise stated, comparisons are made between fiscal Q2 2022 and Q1 2022 results and are in Canadian dollars)
- Net Revenue: increased 0.8%
- Medical: increased 11.6%
- Consumer: decreased 22.4%
- Adj. EBITDA: improved by 25.3%
- Net Profit (Loss): unchanged at $(75.1)M
- SG&A (incl. R&D): reduced by 9.8%
- Cash on Hand: decreased 14.3%
Operational Highlights
- Kilograms Sold: increased 4.5%
- Ave. Net Selling Price: decreased 10.1%
Forward Guidance
- The company
- reaffirmed its goal of Adjusted EBITDA profitability by H1/2023
- expects to realize the upper end of $60M-$80M in cost savings by H1/2023
Stock Performance
Canopy's stock price increased today but still remains down -14.2% YTD and still remains down -75.6% from its 2021 high.


.webp)
Comments
Log in or sign up to join the conversation.